MET and thyroid nodule: Over the last decades, many studies based on gene or protein expression in vitro and in vivo have evaluated the role of biomarkers in determinations of thyroid tumor malignancy [6-10], but candidate biomarkers such as galectin-3 or MET have not shown the sensitivity and specificity needed for a preoperative thyroid nodules screening tool [28].